We are live on ! Find out more
PVMCV

Polaris Venture Management Co V Portfolio holdings

AUM $14.1M
1-Year Est. Return 121.41%
This Fund
S&P 500
This Quarter Est. Return
+15.12%
1 Year Est. Return
+121.41%
3 Year Est. Return
+281.18%
5 Year Est. Return
+1,023.01%
10 Year Est. Return
–
AUM
$60.7M
AUM Growth
-$67.8M
Cap. Flow
-$72.7M
Cap. Flow %
-119.85%
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
–
Reduced
2
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
FATE icon
Fate Therapeutics
FATE
+$9.95M
2
GNCA
Genocea Biosciences, Inc.
GNCA
+$128K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FATE icon
1
Fate Therapeutics
FATE
$300M
$34.2M 56.34%
854,836
-284,947
-25% -$9.95M
LYRA
2
DELISTED
LYRA THERAPEUTICS INC
LYRA
$12.3M 20.29%
22,017
– –
RNAC icon
3
Cartesian Therapeutics
RNAC
$237M
$6.88M 11.34%
92,449
– –
STIM icon
4
Neuronetics
STIM
$160M
$3.56M 5.87%
732,583
– –
XFOR icon
5
X4 Pharmaceuticals
XFOR
$405M
$2.11M 3.48%
10,383
– –
GNCA
6
DELISTED
Genocea Biosciences, Inc.
GNCA
$452K 0.75%
197,345
-48,733
-20% -$128K
PULM icon
7
Pulmatrix
PULM
$6.06M
$428K 0.71%
17,972
– –
ATYR
8
aTyr Pharma
ATYR
$51.9M
$422K 0.7%
130,572
– –
DARE icon
9
Dare Bioscience
DARE
$20.1M
$326K 0.54%
27,187
– –

Similar funds

IFC
Intact Financial Corporation Toronto, Ontario, Canada $14M AUM
AG
Ashmore Group London, United Kingdom $16.3M AUM 57.83% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
IR
Invictus RG Hamilton, Bermuda $8.9M AUM 56.32% 1-Year Est. Return
CCM
Copernicus Capital Management San Francisco, California $8.26M AUM 37.91% 1-Year Est. Return
EIP
Edgbaston Investment Partners $20.3M AUM 35.98% 1-Year Est. Return
AAM
Areion Asset Management Hong Kong $7.82M AUM 16% 1-Year Est. Return
OEP
Ocean Endowment Partners Chicago, Illinois $20.6M AUM 27.63% 1-Year Est. Return

Polaris Venture Management Co V's Q3 2020 Portfolio in Review

As of Q3 2020, Polaris Venture Management Co V held 10 positions worth $60.7M, down 53% from $128M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Polaris Venture Management Co V withdrew a net $72.7M in Q3 2020, closing 1 position and reducing 2 holdings. Its largest reduction was Fate Therapeutics, cutting an estimated $9.95M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 51% a quarter earlier.

  • Polaris Venture Management Co V's biggest Q3 2020 reduction was Fate Therapeutics, cutting an estimated $9.95M.
  • Polaris Venture Management Co V's ten largest holdings make up 100% of its $60.7M portfolio in Q3 2020.
  • Polaris Venture Management Co V opened 0 new positions and closed 1 in Q3 2020.
  • Polaris Venture Management Co V's portfolio value fell 53% quarter-over-quarter to $60.7M.

Based on Polaris Venture Management Co V's 13F filing for Q3 2020, filed 12 Nov 2020.